1. An analysis of the world Muslim population by country/ region. Disponible en: (Último acceso: 14 de abril 2005)
  2. Cano-Pérez JF, Franch J, Mata M. Guía de tratamiento de la diabetes tipo 2 en atención primaria. Recomendaciones clínicas con niveles de evidencia. 4.ª ed. Madrid: Elservier, 2004.
  3. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004; 27: 1.047-1.053.
  4. Abate N. Prevalencia de diabetes mellitus en varios grupos étnicos. J Diabetes Complications. 2003; 17: 39-58.
  5. Goday A, Serrano-Ríos M. Epidemiología de la diabetes mellitus en España. Revisión crítica y nuevas perspectivas. Med Clin (Barc). 1994; 102: 306-315.
  6. Valerio L, Milozzi J, Figueredo A, Reina, Martínez-Cuevas O, Pérez-Quílez O. Prevalence of diabetes mellitus in young Asian Indian immigrants in Santa Coloma de Gramanet (Spain). Med Clin. 2006; 126(2): 53-56.
  7. Uitewaal, Manna D.R, Bruijnzeels, Hoes A.W, Thomas S. Prevalence of type 2 diabetes mellitus, other cardiovascular risk factors, and cardiovascular disease in Turkish and Moroccan immigrants in North West Europe: a systematic review. Prev Med. 2004; 39(6): 1.068-1.076.
  8. Benaji B, Mounib N, Roky R, Aadil N, Houti IE, Moussamih S. Diabetes and Ramadan: Review of the literature. Diabetes Res Clin Pract. 2006; 27.
  9. Al-Arouj M, Bouguerra R, Buse J, Hafez S, Hassanein M, Ibrahim MA, et al. Recommendations for management of diabetes during Ramadan. Diabetes Care. 2005; 28(9): 2.305-2.311.
  10. Chandalia H.B, Bhargav A, Kataria V.Dietary pattern during Ramadan fasting an effect on the metabolic control of diabetes. Practical Diabet. 1987; 4: 287-290.
  11. Chamakhi S, Ftouhi B, Ben Rahmoune N, Ghorbal S, Ben F, Khalifa. Influence of the fast of Ramadan on the balance glycemic to diabetics. Medicographia. 1991; 13 (Supl 1): 27-29.
  12. Mafauzy M, Mohammed WB, Anum M.Y, Zulkifli A, Ruhani AH. A study of fasting diabetic patients during the month of Ramadan. Med J Malaysia. 1990; 45: 14-17.
  13. Athar S, Habib M. Manegement of stable typical 2 diabetes mellitus (NIDDM) during Islamic fasting in Ramadan. En: The First International Congress one Health and Ramadan Casablanca, Morocco. 1994: 203-212 (resumen).
  14. Khoghers Y, Sulaiman M.I, Al-Fayez SF. Ramadan fasting and diabetes safety and state of control. Ann Saudi Med. 1987; 7 (Supl): 5-6.
  15. Khatib FA. effect of fasting in Ramadan on blood glucose and plasma lipids n diabetics with NIDDM. En: The Second International Congress on Ramadan and Health, Istanbul, Turkey. 1997 8: 421-422 (resumen).
  16. Khatib F.A, Shafagoj YA. Metabolic alterations as a result of Ramadan fasting in non-insulin-dependent diabetes mellitus patients in relation to food intake. Saudi Med J. 2004; 25: 1.858-1.963.
  17. Yarahmadi Sh, Larijani B, Bastanhagh MH, Pajouhi M, Baradar Jalili R, Zahedi F, et al. Metabolic and clinical effects of Ramadan fasting in patients with type II diabetes. J Coll Physicians Surg Pak. 2003; 13(6): 329-332.
  18. Bouguerra R, Belkadhi A, Jabrane J, Hamzaoui J, Maatki C, Ben Rayana MC, Ben Slama C. Metabolic effects of the month of Ramadan fasting on type 2 diabetes. East Mediterr Health J. 2003; 9(5-6): 1.099-1.108.
  19. Khaled BM, Bendahmane M, Belbraouet S. Ramadan fasting induces modifications of certain serum components in obese women with type 2 diabetes. Saudi Med J. 2006; 27 (1): 23-26.
  20. Salti I, Benard E, Detournay B, Binachi-Biscay M, Le Brigand C, Voinet C, Jabbar A; EPIDIAR study group. A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study. Diabetes Care. 2004; 27(10): 2.306-2.311.
  21. Beckman JA, Creager MA, Libby P. Diabetes and atherosclerosis: epidemiology, patophysiology and manegement. JAMA. 2002; 287: 2.570-2.581.
  22. Temizhan A, Donderici O, Ouz D, Demirbas B. Is there any effect of Ramadan fasting on acute coronary heart disease events? Int J Cardiol. 1999; 70: 149-153.
  23. Bener A, Hamad A, Fares A, Al-Sayed HM, Al-Swaidi J. Is there any effect of Ramadan fasting on stroke incidence? Singapore Med J. 2006; 47(5): 404-408.
  24. Alghadyan AA. Retinal vein occlusion in Saudi Arabia: possible role of dehydratation. Ann Ophthalmol. 1993; 25: 394- 398.
  25. Belkhadir J, El Gomari H, Klocker N, Mikou A, Naciri M, Sabri M. Muslims with not insulin dependent diabetes fasting during Ramadan. Treatment with glibenclamida. Br Med J. 1994; 307: 292-295.
  26. Sari RR, Balci MK, Akbas SH, Avci B. The effects of diet, sulfonylurea, and repaglinide therapy on clinical and metabolic parameters in type 2 diabetic patients during Ramadan. Endocr Res. 2004; 30: 169-177.
  27. Glimepiride in Ramadan (GLIRA) Study Group. The efficacy and safety of glimepiride in the manegement of type 2 diabetes in Muslim patients during Ramadan. Diabetes Care. 2005; 2.
  28. Mafauzy M. Repaglinide versus glibenclamide treatment of type 2 diabetes during Ramadan fasting. Diabetes Res Clin Pract. 2002; 58: 45-53.
  29. Goday Arno A, Franch Nadal J, Mata Cases M. Criterios de control y pautas de tratamiento combinado en la diabetes tipo 2. Actualización 2004. Med Clin (Barc). 2004; 123: 187-197.
  30. Anwar A, Azmi KN, hamdon BB, Khalid BA. An open label comparative study of glimepiride versus repaglininda in type 2 diabetes mellitus Muslim subjects during the month of Ramadan. Mad J Malaysia. 2006; 61: 28-35.
  31. Akram J, De Verga V. Insulin lispro (Lys B28), Pro (B29) in the treatment of diabetes during the fasting month of Ramadan. Ramadan Study Group. Diabet Med. 1999; 16(10): 861-866.
  32. Mattoo V, Milicevic Z, Malone JK, Schwarzenhofer M, Kanakas A, Levitt LK, et al. A comparison of insulin lispro Mix25 and human insulin 30/70 in the treatment of type 2 diabetes during Ramadan. Diabetes Res Clin Pract. 2003; 59(2): 137-143.